Jefferson Life Sciences
Overview
Jefferson Life Sciences is an investment firm committed to advancing transformative innovations in medicine by investing in early-stage life sciences companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OMass Therapeutics | Oct 2026 | Series C | Co-investor |
| Character Biosciences | Sep 2025 | Series B Extension | Co-investor |
| Juvena Therapeutics | Jan 2026 | Series B | Co-investor |
| Draig Therapeutics | Jul 2026 | Series B | Co-investor |
| Fesarius Therapeutics | Jun 2026 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Jefferson Life Sciences based?
Jefferson Life Sciences is headquartered in New York City, New York, United States.
When was Jefferson Life Sciences founded?
Jefferson Life Sciences was founded in 2025.
How many portfolio companies does Jefferson Life Sciences have?
Jefferson Life Sciences has 5 portfolio companies in Caplight's dataset.
What are some companies in Jefferson Life Sciences's portfolio?
Portfolio companies visible on Caplight include OMass Therapeutics, Character Biosciences, Juvena Therapeutics, Draig Therapeutics, Fesarius Therapeutics.
What was Jefferson Life Sciences's most recent investment shown here?
Jefferson Life Sciences's most recent investment in this portfolio sample was in OMass Therapeutics in 2026.
What sectors does Jefferson Life Sciences focus on?
Jefferson Life Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Jefferson Life Sciences focus on?
Jefferson Life Sciences typically invests at the Mid stage.